Mohs surgery goes exactly as deep as the cancer extends, and not a fraction deeper. There is no preset depth. A surgeon removes one thin layer of tissue, maps it, and examines every edge under a microscope before deciding whether another layer is needed. Some tumors clear after a single pass through the upper skin; others track along nerves or fascia and require removal down to muscle or even bone. The procedure’s defining feature is that depth is determined in real time by the tumor itself, not by a surgical estimate made in advance.
How the Layer-by-Layer Process Actually Works
The name “layer-by-layer” can be misleading. You might picture the surgeon peeling the skin like an onion, removing one anatomical layer of skin at a time. In practice, each “layer” or “stage” is a thin, saucer-shaped piece of tissue that the surgeon removes from the wound bed. The piece is then color-coded with dyes, mapped on a diagram, and taken to an on-site lab where it is frozen, sliced, and examined under a microscope. The surgeon functions as both the person cutting and the person reading the slides, which means they know exactly where on the wound any remaining cancer cells sit.1PubMed Central. Mohs Micrographic Surgery: A Brief Overview
If the margins are clear on all sides and at the base, surgery is done. If cancer cells show up at, say, the three o’clock position on the map, the surgeon goes back and takes another thin layer only from that spot. This targeted approach is what makes the technique tissue-sparing: healthy skin that tested clean on the first pass is left alone while the surgeon chases the tumor wherever it leads. There is no arbitrary safety margin of a centimeter or two around the visible lesion the way there often is in a standard wide excision.
Most cases require between one and three stages, though aggressive or recurrent tumors can require more. Each stage adds roughly 30 to 45 minutes of waiting while slides are prepared. The whole appointment can last anywhere from an hour to most of a day, depending on how many stages the tumor demands.
What Determines How Deep the Surgery Goes
The short answer is tumor biology. A superficial basal cell carcinoma sitting in the upper dermis might clear after one thin stage that barely dips below the skin surface. An aggressive, infiltrative variant of the same cancer type can send finger-like projections deep into the fat layer or along the tissue planes between muscles. Squamous cell carcinoma with perineural invasion, a pattern where cancer cells track along the sheath of a nerve, can pull the surgery much deeper than the original lesion’s surface appearance would suggest.
Location also matters. On the scalp, the soft tissue between skin and bone is relatively thin, so a tumor that invades downward hits periosteum (the membrane covering the skull) quickly. On the back or thigh, by contrast, there is a thick cushion of subcutaneous fat before the surgeon would encounter muscle. Anatomical site determines not just the theoretical depth the tumor could reach but also how many critical structures lie in its path.
Dr. Frederic Mohs originally developed the technique specifically for complex and recurrent skin cancers in sensitive areas like the face, ears, and hands, where preserving as much healthy tissue as possible has obvious cosmetic and functional importance.2PubMed Central. Layers of Genius: The Mohs Method and Its Maverick Inventor The procedure’s real-time feedback loop makes it uniquely suited to these regions because the surgeon never removes more than the cancer requires.
When Mohs Reaches Bone, Muscle, or Fascia
It is uncommon, but Mohs surgery can extend down to the deepest structures the body has to offer. Published case reports document tumors that required excision down to the periosteum of the skull, and wounds that exposed bare bone after clearance. In one reported case of dermatofibrosarcoma protuberans on the sole of the foot, the surgery unmasked tumor infiltration that had grown around the plantar aponeurosis and into the underlying muscle fascia.3PubMed. Dermatofibrosarcoma growing around plantar aponeurosis: excision by Mohs micrographic surgery That kind of depth is unusual, but it illustrates the principle: the surgery follows the cancer regardless of how deep the trail goes.
In areas like the temple, nose, and periorbital region (around the eye socket), the tissue between skin and bone or cartilage is thin enough that even a moderately deep tumor can bring the surgeon close to critical structures. The scalp is another area where depth becomes a practical concern quickly, because there is not much tissue separating the skin surface from the skull. In these situations, the Mohs surgeon sometimes works alongside other specialists to manage reconstruction of the resulting defect.
Tissue Sparing Compared to Standard Excision
One of the strongest arguments for Mohs is how little healthy tissue it sacrifices. In a standard wide excision, the surgeon removes the visible tumor plus a predetermined margin of clinically normal-looking skin, typically four to six millimeters or more depending on the cancer type. That margin is a safety buffer because the surgeon cannot see microscopic tumor extensions in real time. The trade-off is a larger wound and more lost tissue.
A study comparing Mohs to standard excision for infiltrative basal cell carcinoma, one of the more aggressive common subtypes, found that Mohs produced defects roughly half the size. The median defect after Mohs was about 154 square millimeters, compared to an estimated 298 square millimeters for a standard excision of the same tumors, a tissue-sparing effect of about 46 percent.4J Am Acad Dermatol. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma That difference is significant on the face, where every millimeter of preserved tissue can affect whether a scar pulls on an eyelid or distorts a lip.
The tissue-sparing advantage gets even more meaningful for cancers with irregular, unpredictable borders. A tumor that extends farther in one direction than the others will be caught by the margin mapping, and the surgeon takes more tissue only where the cancer actually is. Standard excision, by contrast, has to use the same margin distance in every direction, which means over-cutting in the areas where the tumor’s border is close to the surface.
Nerve Risks When the Surgery Goes Deep
Going deeper means encountering motor and sensory nerves. On the face, one of the most concerning structures is the temporal branch of the facial nerve, which controls the muscles that raise the eyebrow and close the upper eyelid. Damage to it can leave a person unable to raise an eyebrow or, in worse cases, with incomplete eyelid closure.
A large study of over 600 Mohs cases in the area overlying this nerve found that about 4.5 percent of patients had postoperative nerve dysfunction. The risk was not random: it climbed steeply with tumor size and defect size. When the wound measured three centimeters or more after surgery, the odds of nerve damage were roughly 37 to 40 times higher than for smaller defects. Reassuringly, no patients with a defect smaller than two centimeters had any nerve damage at all.5PubMed. Damage to the Temporal Branch of the Facial Nerve From Mohs Micrographic Surgery Aggressive tumor histology, recurrent tumors, and immunosuppression also increased the risk. The takeaway for patients is that small, first-time tumors in this area carry minimal nerve risk, while large or previously treated cancers require a frank conversation about the possibility.
Elsewhere on the body, deep excision can damage sensory nerves, resulting in numbness around the surgical site. Numbness after Mohs is fairly common and usually temporary, resolving over weeks to months as nerves regenerate. Permanent sensory loss is possible but rare with small defects.
What Happens After the Last Layer Is Cleared
Once the margins are cancer-free, the surgeon is left with a wound that needs to be closed or allowed to heal. The depth and location of the defect drive the reconstruction strategy. For shallow wounds or those in concave areas of the face, sometimes the best option is to let the wound heal on its own, a process called secondary intention healing. Despite sounding crude, this approach produces surprisingly good cosmetic results in certain anatomical zones like the inner corner of the eye, the ear’s antihelix, and the temple. It is safe, cost-effective, and has the added advantage of making it easier to monitor the site for recurrence, since no flap or graft is covering the area.6Actas Dermo-Sifiliográficas. Practical Dermatology Secondary Intention Healing After Mohs Micrographic Surgery: An Updated Review of Classic and Novel Applications, Benefits and Complications
For larger or deeper defects, direct closure (stitching the edges together) remains the gold standard when the surrounding skin is loose enough to allow it. When the wound is too large or too deep for that, flaps and grafts come into play. On the cheek, for example, a cervicofacial advancement flap, which borrows nearby skin and slides it into the defect, handles most situations that direct closure cannot.7PubMed Central. Approaches to Cheek Reconstruction following Mohs Surgery On the nose, cartilage grafts may be needed if the tumor invaded deeply enough to remove structural support.
The depth of the wound also affects healing time and postoperative concerns. A study of over 1,500 Mohs patients found that about 17 percent contacted their surgeon’s office within 90 days, most commonly about wound concerns, bleeding, or pain. Patients whose wounds healed by secondary intention or required grafts were more likely to reach out than those who had a simple linear closure.8PubMed. Factors Associated With Patient-Initiated Communication After Mohs Micrographic Surgery Deeper and more complex wounds, in other words, demand more aftercare attention.
Cure Rates and What Affects Recurrence
Mohs has the highest cure rate of any treatment for the most common skin cancers. It is considered the standard of care for high-risk basal cell carcinomas and cutaneous squamous cell carcinomas, and it is increasingly used for melanoma and rarer tumors as well.9PubMed Central. Mohs micrographic surgery: a review of indications, technique, outcomes, and considerations The cure rate for primary basal cell carcinoma treated with Mohs is often quoted above 99 percent at five years, and squamous cell carcinoma cure rates are only slightly lower.
Recurrence does still happen, though, and the risk is not the same for everyone. A large prospective registry found recurrence rates of about 1.3 per 100 person-years for basal cell carcinoma and 4.5 per 100 person-years for squamous cell carcinoma, with the rate staying constant over the first five years of follow-up.10PubMed Central. Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery) Squamous cell carcinoma carries a notably higher recurrence risk, especially in immunosuppressed patients. The steady recurrence rate over five years is a useful detail for patients wondering how long they need close follow-up: the answer is at least five years, without tapering off.
Prior treatment is another important factor. A meta-analysis found that basal cell carcinomas previously treated by another method before Mohs had a recurrence rate about 2.4 times higher than tumors being treated for the first time. Patients who had previously received radiation therapy fared even worse, with a roughly 2.5-fold higher recurrence rate compared to those without prior radiation.11PubMed. Previous therapy and the recurrence rate of basal cell carcinoma after Mohs surgery: a meta-analysis The likely explanation is that prior treatment can alter the tissue in ways that make residual cancer harder to detect and map accurately, so the Mohs surgeon is starting from a more challenging baseline.
The Pain and Anesthesia Question
Since Mohs can involve multiple stages over several hours, patients understandably worry about pain. The entire procedure is done under local anesthesia, not general. You are awake the whole time. The surgeon injects lidocaine (the same numbing agent a dentist uses) into the area before each stage. Most patients report that the initial injection stings, but that the removal itself is painless.
Researchers are actively studying whether adding a regional nerve block on top of the standard lidocaine injection reduces pain and anxiety during facial and scalp Mohs procedures. A clinical trial is testing whether a lidocaine nerve block, compared to a saline placebo, makes a meaningful difference in patient comfort.12ClinicalTrials.gov. Comparing Numbing Techniques in Mohs Micrographic Surgery For now, the standard approach of local infiltration alone keeps most patients comfortable, though deeper or more extensive cases can require additional injections as the anesthetic wears off between stages.
The waiting between stages is often described as the most uncomfortable part of the experience, not because of physical pain, but because of anxiety and boredom. Many Mohs offices are set up to accommodate this, letting patients read, use their phone, or eat snacks between rounds. If the surgery extends to deeper tissue and requires a longer or more complex reconstruction, the total time in the office can stretch to four or five hours.
Cost Compared to Standard Surgery
A common assumption is that Mohs must cost more because it involves on-site pathology and a potentially long appointment. For certain tumor types, the opposite appears to be true. A cost-effectiveness analysis of intermediate-risk squamous cell carcinoma found that Mohs was actually about $334 less expensive over five years than a wide local excision, while also producing slightly better quality-of-life outcomes. The probability that Mohs was the more cost-effective option in that analysis was over 99 percent.13PubMed Central. Cost effectiveness of intermediate-risk squamous cell carcinoma treated with Mohs micrographic surgery compared with wide local excision
The cost advantage comes partly from the single-visit structure: surgery, pathology, and often reconstruction happen in one appointment in one office, rather than requiring a separate pathology lab, a second visit for results, and potentially a third visit if margins are positive. The lower recurrence rate also reduces downstream costs from re-excision, imaging, and additional follow-up. For deeper tumors that require multiple stages, the per-visit cost can climb, but the five-year total often still compares favorably to alternatives that carry higher recurrence risk.
Frozen-Section Processing and the Lab Side
The on-site lab is what makes the entire layer-by-layer concept possible. After each stage, the excised tissue is pressed flat, frozen in a cryostat (a very cold cutting machine), and sliced into thin sections that are mounted on glass slides and stained. The surgeon then examines these frozen sections under a microscope, comparing what they see to the color-coded map to determine exactly where residual cancer remains.
There is more variability in how different Mohs offices handle this processing than you might expect. The techniques for flattening, orienting, and sectioning tissue differ from practice to practice, and the quality of frozen sections depends heavily on the skill of the histotechnician preparing them.14PubMed Central. Frozen-Section Tissue Processing in Mohs Surgery This is part of why Mohs is a fellowship-trained subspecialty: the surgeon needs to be proficient not just in cutting and sewing but in reading tissue under a microscope, and in directing the lab team to produce slides that accurately represent every margin of the specimen. When the tumor extends deep, getting a true cross-section of the deep margin is technically harder, and errors in tissue processing at depth can lead to a false-negative reading that misses residual cancer.
Some surgeons are exploring presurgical tumor mapping with confocal microscopy, an imaging technology that can visualize cellular detail in living tissue before the first cut. The idea is to better define the tumor’s borders ahead of time, potentially reducing the number of stages needed and improving accuracy when the tumor’s depth is uncertain.